Morimatsu International Listed in Hong Kong (2155.HK)

 On the afternoon of 28 June 2021, Morimatsu International Holdings Ltd. (hereinafter as "Morimatsu International") was officially listed on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEx"). This very significant moment announces the official landing of Morimatsu International in the capital market and embarking for a new journey. READ MORE



Morimatsu International Listed in Hong Kong (2155.HK)
7/2/2021
 On the afternoon of 28 June 2021, Morimatsu International Holdings Ltd. (hereinafter as "Morimatsu Intern...
Press Release - Pharmadule Morimatsu Completed the Setting of KUBio Modules for GE Fit-Out of The Lonza Biologics Facility in Guangzhou
12/12/2019
Press Release On the December 12th, with the last six modules being lifted and placed within one day, 54 modules de...
Press Release-GE Healthcare Life Sciences allies with Pharmadule Morimatsu to expand KUBio
11/21/2019
Press Release - Uppsala Sweden The KUBio "factory in a box" is expanding to accelerate the accessibility of biother...
Shanghai Morimatsu Wins Highest Honor from 50, 000 Suppliers of P&G
3/14/2019
On the first day of Chinese New Year 2019, Shanghai Morimatsu is awarded the highest honor of "TOP 10 Partner of the...
Pharmadule Morimatsu Awarded Modular Biomanufacturing Facility
10/4/2018
Press Release | Pharmadule Morimatsu AB Nacka, Stockholm: - Pharmadule Morimatsu has been awarded the contract for ...
Pharmadule Morimatsu wins basic design order from a highly recognized Global Biotech company
9/28/2018
Press Release | Pharmadule Morimatsu AB   Nacka, Stockholm: - Swedish-based turn key solution provider of mod...
Pharmadule Morimatsu wins European design order for a modular F&F facility
9/27/2018
Press Release | Pharmadule Morimatsu AB Nacka, Stockholm: - Pharmadule Morimatsu AB the Swedish-based world-wide tu...
New design order to Pharmadule Morimatsu for modular facilities within the FMCG area
3/8/2017
Pharmadule Morimatsu AB has received an order from a highly recognized UK Global corporation to execute a Design stu...
New design order for a modular MAB facility to Pharmadule Morimatsu
12/19/2016
Pharmadule Morimatsu AB has received an order from a Chinese corporation to execute a Conceptual & Basic Design ...
We congratulate Merck Category Winner for Operational Excellence
3/21/2013
Category Winner for Operational Excellence Merck & Co., Inc.  Vaccine and Biologics Sterile Facility (VBS...
 
Pharmadule Morimatsu AB  |   DanvikCenter 28  |   SE - 131 30 Nacka  Sweden  |   Phone: +46 (0)8 587 42 000  |   Email: info@pharmadule.com